Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amniotic Fluid | 6 | 2025 | 154 | 2.660 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 7 | 2025 | 87 | 2.350 |
Why?
|
| Tissue Scaffolds | 6 | 2025 | 85 | 2.240 |
Why?
|
| Amnion | 10 | 2016 | 40 | 1.620 |
Why?
|
| Umbilical Cord | 3 | 2025 | 59 | 1.600 |
Why?
|
| Ovarian Neoplasms | 4 | 2021 | 468 | 1.510 |
Why?
|
| Biocompatible Materials | 3 | 2025 | 129 | 1.470 |
Why?
|
| Collagen | 3 | 2025 | 330 | 1.460 |
Why?
|
| Nanotechnology | 2 | 2019 | 52 | 1.090 |
Why?
|
| Chondroitin Sulfates | 2 | 2017 | 15 | 1.070 |
Why?
|
| Tissue Engineering | 3 | 2017 | 184 | 1.010 |
Why?
|
| Immunotherapy | 3 | 2021 | 752 | 0.980 |
Why?
|
| Foreign-Body Reaction | 1 | 2025 | 16 | 0.940 |
Why?
|
| Biomimetic Materials | 4 | 2021 | 14 | 0.940 |
Why?
|
| Macrophages | 7 | 2025 | 711 | 0.900 |
Why?
|
| Prostheses and Implants | 2 | 2025 | 152 | 0.880 |
Why?
|
| Regeneration | 2 | 2017 | 231 | 0.850 |
Why?
|
| Bone Marrow Cells | 4 | 2015 | 275 | 0.830 |
Why?
|
| Horses | 10 | 2016 | 102 | 0.810 |
Why?
|
| Primary Cell Culture | 2 | 2025 | 110 | 0.770 |
Why?
|
| Immunity, Innate | 1 | 2025 | 417 | 0.760 |
Why?
|
| Amphibians | 1 | 2021 | 4 | 0.720 |
Why?
|
| Cell Differentiation | 15 | 2024 | 2045 | 0.700 |
Why?
|
| Down Syndrome | 1 | 2023 | 231 | 0.680 |
Why?
|
| Polyglycolic Acid | 3 | 2016 | 26 | 0.680 |
Why?
|
| Regenerative Medicine | 2 | 2021 | 37 | 0.670 |
Why?
|
| Animals | 40 | 2025 | 36557 | 0.660 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 698 | 0.640 |
Why?
|
| Lactic Acid | 3 | 2016 | 166 | 0.640 |
Why?
|
| Tumor Escape | 1 | 2019 | 65 | 0.640 |
Why?
|
| Exosomes | 3 | 2024 | 58 | 0.600 |
Why?
|
| Cells, Cultured | 15 | 2017 | 3188 | 0.590 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 128 | 0.580 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 190 | 0.570 |
Why?
|
| Cell Culture Techniques | 5 | 2016 | 294 | 0.540 |
Why?
|
| Osteoblasts | 2 | 2015 | 166 | 0.540 |
Why?
|
| Nanoparticles | 3 | 2019 | 290 | 0.530 |
Why?
|
| Chondrogenesis | 2 | 2016 | 29 | 0.520 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 109 | 0.510 |
Why?
|
| Chondrocytes | 1 | 2016 | 51 | 0.490 |
Why?
|
| Culture Media, Conditioned | 2 | 2016 | 86 | 0.490 |
Why?
|
| Poloxamer | 1 | 2014 | 14 | 0.460 |
Why?
|
| Cell Separation | 3 | 2011 | 234 | 0.450 |
Why?
|
| Chitosan | 1 | 2014 | 32 | 0.450 |
Why?
|
| Bupivacaine | 1 | 2014 | 29 | 0.450 |
Why?
|
| Wound Healing | 4 | 2025 | 488 | 0.440 |
Why?
|
| Chorionic Villi | 2 | 2024 | 22 | 0.440 |
Why?
|
| Environment | 1 | 2015 | 156 | 0.440 |
Why?
|
| Drug Carriers | 1 | 2014 | 119 | 0.430 |
Why?
|
| Cell Lineage | 2 | 2015 | 370 | 0.430 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2013 | 5 | 0.420 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 90 | 0.420 |
Why?
|
| Cytokines | 5 | 2025 | 1401 | 0.420 |
Why?
|
| Cell Movement | 1 | 2017 | 920 | 0.420 |
Why?
|
| Platelet-Rich Plasma | 3 | 2020 | 18 | 0.420 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 1853 | 0.420 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 316 | 0.410 |
Why?
|
| Transcriptome | 3 | 2025 | 1138 | 0.410 |
Why?
|
| Cell Proliferation | 12 | 2019 | 2563 | 0.400 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2012 | 28 | 0.390 |
Why?
|
| Bone and Bones | 1 | 2015 | 311 | 0.390 |
Why?
|
| Spermatogenesis | 1 | 2013 | 178 | 0.380 |
Why?
|
| Pregnancy | 6 | 2025 | 7570 | 0.370 |
Why?
|
| Liposomes | 1 | 2012 | 207 | 0.360 |
Why?
|
| Stem Cells | 4 | 2023 | 754 | 0.360 |
Why?
|
| Inflammation Mediators | 4 | 2016 | 259 | 0.350 |
Why?
|
| Cell Size | 1 | 2011 | 90 | 0.350 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 178 | 0.350 |
Why?
|
| Uterus | 1 | 2014 | 587 | 0.340 |
Why?
|
| Rats, Inbred Lew | 4 | 2017 | 70 | 0.330 |
Why?
|
| Female | 22 | 2025 | 71928 | 0.320 |
Why?
|
| Mice, Inbred BALB C | 2 | 2025 | 1089 | 0.310 |
Why?
|
| Neoplasms | 2 | 2021 | 3038 | 0.310 |
Why?
|
| Endometrium | 3 | 2016 | 289 | 0.310 |
Why?
|
| Mice | 7 | 2025 | 19055 | 0.300 |
Why?
|
| Biomimetics | 2 | 2021 | 18 | 0.300 |
Why?
|
| Flow Cytometry | 5 | 2015 | 837 | 0.280 |
Why?
|
| Delayed-Action Preparations | 3 | 2016 | 124 | 0.260 |
Why?
|
| Kinetics | 3 | 2019 | 1357 | 0.260 |
Why?
|
| Cell-Derived Microparticles | 2 | 2016 | 30 | 0.260 |
Why?
|
| Rats | 6 | 2020 | 3890 | 0.250 |
Why?
|
| Tendons | 4 | 2016 | 38 | 0.240 |
Why?
|
| Mannose | 1 | 2025 | 28 | 0.240 |
Why?
|
| Cross-Linking Reagents | 1 | 2025 | 55 | 0.240 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 96 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4879 | 0.210 |
Why?
|
| Particle Size | 2 | 2014 | 148 | 0.200 |
Why?
|
| Humans | 20 | 2025 | 134156 | 0.200 |
Why?
|
| Chromosomes | 1 | 2023 | 164 | 0.200 |
Why?
|
| Epithelial Cells | 4 | 2015 | 937 | 0.190 |
Why?
|
| Beclin-1 | 1 | 2021 | 29 | 0.190 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 2771 | 0.190 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 46 | 0.180 |
Why?
|
| Spermatozoa | 2 | 2016 | 251 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 3798 | 0.180 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 56 | 0.180 |
Why?
|
| Immunomodulation | 1 | 2021 | 81 | 0.180 |
Why?
|
| Cell Shape | 3 | 2016 | 70 | 0.180 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 359 | 0.180 |
Why?
|
| Biology | 1 | 2021 | 29 | 0.180 |
Why?
|
| Ascites | 1 | 2021 | 111 | 0.180 |
Why?
|
| Inflammation | 3 | 2021 | 1595 | 0.170 |
Why?
|
| Cell Communication | 1 | 2021 | 188 | 0.170 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 589 | 0.170 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 21 | 0.160 |
Why?
|
| Hyaluronan Receptors | 2 | 2017 | 69 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 189 | 0.160 |
Why?
|
| Mammals | 1 | 2021 | 282 | 0.160 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 2669 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4808 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 91 | 0.160 |
Why?
|
| Osteogenesis | 4 | 2015 | 168 | 0.160 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 58 | 0.150 |
Why?
|
| Cell Survival | 3 | 2016 | 890 | 0.150 |
Why?
|
| Cattle | 3 | 2016 | 589 | 0.150 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 467 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1923 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2021 | 1332 | 0.150 |
Why?
|
| Antigens, Differentiation | 2 | 2016 | 69 | 0.150 |
Why?
|
| Hydrogels | 2 | 2020 | 109 | 0.150 |
Why?
|
| RNA | 2 | 2013 | 607 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 358 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2019 | 185 | 0.140 |
Why?
|
| Adenoma | 1 | 2019 | 143 | 0.140 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2015 | 169 | 0.130 |
Why?
|
| Endometritis | 1 | 2016 | 9 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2019 | 449 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 825 | 0.130 |
Why?
|
| Tenocytes | 1 | 2016 | 4 | 0.130 |
Why?
|
| Receptors, Leptin | 1 | 2016 | 42 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 65 | 0.120 |
Why?
|
| RNAi Therapeutics | 1 | 2016 | 18 | 0.120 |
Why?
|
| Sperm Head | 2 | 2013 | 9 | 0.120 |
Why?
|
| DNA | 2 | 2013 | 1682 | 0.120 |
Why?
|
| Microspheres | 1 | 2016 | 75 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2019 | 970 | 0.120 |
Why?
|
| Interleukin-4 | 1 | 2016 | 148 | 0.120 |
Why?
|
| Hernia, Ventral | 1 | 2015 | 44 | 0.120 |
Why?
|
| Bone Regeneration | 1 | 2015 | 24 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 1765 | 0.120 |
Why?
|
| Surgical Mesh | 1 | 2015 | 72 | 0.120 |
Why?
|
| Granulosa Cells | 1 | 2016 | 142 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2016 | 361 | 0.120 |
Why?
|
| Herniorrhaphy | 1 | 2015 | 83 | 0.120 |
Why?
|
| Technology, Pharmaceutical | 1 | 2014 | 21 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 56 | 0.110 |
Why?
|
| Fertilization in Vitro | 1 | 2016 | 163 | 0.110 |
Why?
|
| Leptin | 1 | 2016 | 224 | 0.110 |
Why?
|
| Solubility | 1 | 2014 | 145 | 0.110 |
Why?
|
| Breast | 1 | 2016 | 218 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2025 | 4934 | 0.110 |
Why?
|
| Ethinyl Estradiol | 1 | 2013 | 11 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 470 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 721 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 61 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2014 | 194 | 0.100 |
Why?
|
| Ligaments | 1 | 2013 | 21 | 0.100 |
Why?
|
| Crops, Agricultural | 1 | 2013 | 20 | 0.100 |
Why?
|
| Carboxylesterase | 1 | 2013 | 15 | 0.100 |
Why?
|
| Aphids | 1 | 2013 | 14 | 0.100 |
Why?
|
| Tendon Injuries | 1 | 2013 | 18 | 0.100 |
Why?
|
| Insecticide Resistance | 1 | 2013 | 39 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2015 | 451 | 0.100 |
Why?
|
| Avidin | 1 | 2012 | 19 | 0.100 |
Why?
|
| Lewis X Antigen | 1 | 2012 | 11 | 0.100 |
Why?
|
| Insect Proteins | 1 | 2013 | 111 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 738 | 0.100 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2012 | 29 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 124 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 143 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2012 | 74 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 1187 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1310 | 0.090 |
Why?
|
| Fetal Stem Cells | 1 | 2011 | 5 | 0.090 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 271 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2738 | 0.090 |
Why?
|
| Reproduction | 1 | 2013 | 245 | 0.090 |
Why?
|
| Breeding | 1 | 2010 | 24 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 69 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 1157 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 363 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 299 | 0.090 |
Why?
|
| Zebrafish | 1 | 2013 | 421 | 0.080 |
Why?
|
| Phenotype | 2 | 2021 | 4598 | 0.080 |
Why?
|
| Fetal Blood | 1 | 2011 | 178 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2010 | 84 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 6610 | 0.080 |
Why?
|
| Dogs | 1 | 2010 | 798 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1627 | 0.080 |
Why?
|
| Cell Line | 1 | 2014 | 2864 | 0.080 |
Why?
|
| Organoplatinum Compounds | 1 | 2008 | 34 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2090 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1044 | 0.070 |
Why?
|
| Chromatin | 1 | 2010 | 617 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 1072 | 0.060 |
Why?
|
| Apoptosis | 3 | 2019 | 1946 | 0.060 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 690 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2008 | 294 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2015 | 44 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 2016 | 319 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2016 | 247 | 0.050 |
Why?
|
| Sperm Motility | 2 | 2016 | 113 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 548 | 0.050 |
Why?
|
| Italy | 2 | 2013 | 130 | 0.050 |
Why?
|
| Staining and Labeling | 2 | 2013 | 187 | 0.050 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 143 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 232 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 401 | 0.040 |
Why?
|
| Male | 6 | 2020 | 66127 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 70 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 406 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2021 | 398 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 463 | 0.040 |
Why?
|
| Integrative Medicine | 1 | 2019 | 11 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 233 | 0.040 |
Why?
|
| Autophagy | 1 | 2021 | 429 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 559 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2915 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2019 | 247 | 0.030 |
Why?
|
| Monocytes | 1 | 2019 | 360 | 0.030 |
Why?
|
| Collagenases | 1 | 2016 | 18 | 0.030 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2016 | 23 | 0.030 |
Why?
|
| Follicular Fluid | 1 | 2016 | 8 | 0.030 |
Why?
|
| Acrosome Reaction | 1 | 2016 | 11 | 0.030 |
Why?
|
| Sperm Capacitation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Methacrylates | 1 | 2016 | 18 | 0.030 |
Why?
|
| Adsorption | 1 | 2016 | 37 | 0.030 |
Why?
|
| Cations | 1 | 2016 | 40 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2016 | 31 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 703 | 0.030 |
Why?
|
| Acellular Dermis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Arginase | 1 | 2016 | 35 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2015 | 30 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 103 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 104 | 0.030 |
Why?
|
| Bone Substitutes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 71 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2015 | 93 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 133 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 128 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 118 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 87 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2015 | 104 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 398 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1317 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 191 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 720 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 729 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 780 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3668 | 0.030 |
Why?
|
| Stage-Specific Embryonic Antigens | 1 | 2013 | 1 | 0.030 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ectoderm | 1 | 2013 | 32 | 0.030 |
Why?
|
| Cats | 1 | 2013 | 124 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 486 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 112 | 0.030 |
Why?
|
| Propidium | 1 | 2013 | 4 | 0.030 |
Why?
|
| Mesoderm | 1 | 2013 | 113 | 0.030 |
Why?
|
| Parthenogenesis | 1 | 2013 | 3 | 0.030 |
Why?
|
| Progesterone | 1 | 2016 | 635 | 0.030 |
Why?
|
| Diploidy | 1 | 2013 | 39 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 608 | 0.030 |
Why?
|
| Decorin | 1 | 2012 | 8 | 0.030 |
Why?
|
| Cytogenetic Analysis | 1 | 2013 | 82 | 0.030 |
Why?
|
| Tenascin | 1 | 2012 | 33 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2012 | 130 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 249 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1219 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 672 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1621 | 0.020 |
Why?
|
| Rupture | 1 | 2011 | 34 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 70 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 1472 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 29 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 5086 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2011 | 33 | 0.020 |
Why?
|
| Sperm Tail | 1 | 2010 | 8 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 111 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 2137 | 0.020 |
Why?
|
| Sheep | 1 | 2011 | 237 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7217 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 252 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2016 | 951 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 3180 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3980 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 547 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2008 | 838 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 1004 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2008 | 628 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3178 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17540 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21775 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 29399 | 0.010 |
Why?
|